We are live on ! Find out more
ATRA icon

Atara Biotherapeutics
ATRA

84 hedge funds and large institutions have $493M invested in Atara Biotherapeutics in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $540K | Put options by funds: $261K

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

49% more capital invested

Capital invested by funds: $330M → $493M (+$163M)

48% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 21

0.08% more ownership

Funds ownership: 3.22% → 3.3% (+0.08%)

1% less funds holding

Funds holding: 85 → 84 (-1)

Holders
84
Holders Change
-1
Holders Change %
-1.18%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
31
Reduced
21
Closed
8
Calls
$540K
Puts
$261K
Net Calls
+$279K
Net Calls Change
+$279K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$28.4M
2
BM
Bridger Management
New York
+$10.1M
3
RI
RTW Investments
New York
+$8.88M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$6.14M
5
EC
EcoR1 Capital
California
+$3.63M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.5M
2
UBS AM
UBS AM
Illinois
-$6.75M
3
SPC
Slate Path Capital
New York
-$6.75M
4
TA
Teachers Advisors
New York
-$1.51M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
51
Millennium Management
New York
$280K -$210K -507 -48%
NFA
52
Nationwide Fund Advisors
Ohio
$277K -$13.2K -32 -6%
EMG
53
Ellington Management Group
Connecticut
$220K +$177K +428 New
HP
54
Harbourvest Partners
Massachusetts
$217K – – –
State Board of Administration of Florida Retirement System
55
State Board of Administration of Florida Retirement System
Florida
$211K – – –
VOYA Investment Management
56
VOYA Investment Management
Georgia
$209K – – –
Creative Planning
57
Creative Planning
Kansas
$205K – – –
EP
58
Elkfork Partners
Oregon
$196K – – –
CMBA
59
C.M. Bidwell & Associates
Hawaii
$195K +$157K +380 New
Barclays
60
Barclays
United Kingdom
$189K +$8.28K +20 +6%
DekaBank Deutsche Girozentrale
61
DekaBank Deutsche Girozentrale
Germany
$185K +$152K +368 New
GHCM
62
Glen Harbor Capital Management
California
$161K – – –
Zurich Cantonal Bank
63
Zurich Cantonal Bank
Switzerland
$132K +$106K +256 New
MCIM
64
Meadow Creek Investment Management
Georgia
$127K – – –
Legal & General Group
65
Legal & General Group
United Kingdom
$120K -$1.66K -4 -2%
Deutsche Bank
66
Deutsche Bank
Germany
$118K -$141K -340 -59%
SG Americas Securities
67
SG Americas Securities
New York
$105K -$96K -232 -53%
FCM
68
Flinton Capital Management
Pennsylvania
$92K – – –
CLOS
69
Compagnie Lombard Odier SCmA
Switzerland
$92K +$33.1K +80 +80%
Acadian Asset Management
70
Acadian Asset Management
Massachusetts
$73K +$59.2K +143 New
CG
71
Cutler Group
California
$41K +$31.5K +76 +1,900%
AIP
72
Ameritas Investment Partners
Nebraska
$37K +$29.8K +72 New
Canada Life
73
Canada Life
Manitoba, Canada
$34K – – –
Russell Investments Group
74
Russell Investments Group
United Kingdom
$31K -$91.1K -220 -78%
Envestnet Asset Management
75
Envestnet Asset Management
Illinois
$29K +$1.66K +4 +8%
1 2
3
4

ATRA Hedge Fund Activity: Q1 2017 in Review

84 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Atara Biotherapeutics (ATRA) for Q1 2017, worth a combined $493M — up 49% from $330M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ATRA positions and 8 closed out — a net gain of 4 holders — while 31 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $28.4M. The largest seller was Fidelity Investments, cutting an estimated $13.5M.

  • 84 institutional investors held Atara Biotherapeutics (ATRA) as of Q1 2017, down from 85 in Q4 2016.
  • Funds reported $493M of Atara Biotherapeutics stock for Q1 2017, up 49% quarter-over-quarter.
  • 12 funds opened new Atara Biotherapeutics positions in Q1 2017 and 8 closed out, a net change of +4 holders.
  • The largest Atara Biotherapeutics buyer in Q1 2017 was BlackRock, an estimated $28.4M added.
  • The largest Atara Biotherapeutics seller in Q1 2017 was Fidelity Investments, an estimated $13.5M sold.

Based on aggregated 13F filings for Q1 2017.